BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15684297)

  • 1. Long-term clearance from small airways in patients with cystic fibrosis.
    Lindström M; Camner P; Falk R; Hjelte L; Philipson K; Svartengren M
    Eur Respir J; 2005 Feb; 25(2):317-23. PubMed ID: 15684297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clearance from small airways in subjects with ciliary dysfunction.
    Lindström M; Falk R; Hjelte L; Philipson K; Svartengren M
    Respir Res; 2006 May; 7(1):79. PubMed ID: 16712736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clearance from small airways in patients with chronic bronchitis: experimental and theoretical data.
    Svartengren M; Svartengren K; Europe E; Falk R; Hofmann W; Sturm R; Philipson K; Camner P
    Exp Lung Res; 2004; 30(5):333-53. PubMed ID: 15204827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clearance from small airways decreases with age.
    Svartengren M; Falk R; Philipson K
    Eur Respir J; 2005 Oct; 26(4):609-15. PubMed ID: 16204590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracheobronchial deposition and clearance in small airways in asthmatic subjects.
    Svartengren K; Philipson K; Svartengren M; Anderson M; Camner P
    Eur Respir J; 1996 Jun; 9(6):1123-9. PubMed ID: 8804926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Eberl S; Tomlinson C; Daviskas E; Regnis JA; Bailey DL; Torzillo PJ; Menache M; Bye PT
    J Aerosol Med; 2000; 13(2):73-86. PubMed ID: 11010597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia.
    Regnis JA; Zeman KL; Noone PG; Knowles MR; Bennett WD
    Exp Lung Res; 2000; 26(3):149-62. PubMed ID: 10813088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adrenergic stimulation on clearance from small ciliated airways in healthy subjects.
    Svartengren K; Philipson K; Svartengren M; Camner P
    Exp Lung Res; 1998; 24(2):149-58. PubMed ID: 9555573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis.
    Brown JS; Zeman KL; Bennett WD
    J Aerosol Med; 2001; 14(4):443-54. PubMed ID: 11791685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of particles from small ciliated airways.
    Falk R; Philipson K; Svartengren M; Jarvis N; Bailey M; Camner P
    Exp Lung Res; 1997; 23(6):495-515. PubMed ID: 9358233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bronchiolar deposition and retention of 6-, 8- and 10-micrograms particles.
    Camner P; Anderson M; Philipson K; Bailey A; Hashish A; Jarvis N; Bailey M; Svartengren M
    Exp Lung Res; 1997; 23(6):517-35. PubMed ID: 9358234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition and extremely slow inhalations of particles. Limited effect of induced airway obstruction.
    Svartengren M; Svartengren K; Aghaie F; Philipson K; Camner P
    Exp Lung Res; 1999 Jun; 25(4):353-66. PubMed ID: 10378105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway.
    Corcoran TE; Thomas KM; Myerburg MM; Muthukrishnan A; Weber L; Frizzell R; Pilewski JM
    Eur Respir J; 2010 Apr; 35(4):781-6. PubMed ID: 19717485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways.
    Xie Y; Ostedgaard L; Abou Alaiwa MH; Lu L; Fischer AJ; Stoltz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S171-S176. PubMed ID: 30431346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect.
    McShane D; Davies JC; Wodehouse T; Bush A; Geddes D; Alton EW
    Eur Respir J; 2004 Jul; 24(1):95-100. PubMed ID: 15293610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition and clearance in large and small airways in chronic bronchitis.
    Svartengren K; Ericsson CH; Svartengren M; Mossberg B; Philipson K; Camner P
    Exp Lung Res; 1996; 22(5):555-76. PubMed ID: 8886759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects.
    Möller W; Häussinger K; Winkler-Heil R; Stahlhofen W; Meyer T; Hofmann W; Heyder J
    J Appl Physiol (1985); 2004 Dec; 97(6):2200-6. PubMed ID: 15347631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.